Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.00705
+0.00055 (8.46%)
At close: May 12, 2026
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees decreased by 15 or -83.33% compared to the previous year.
Employees
3
Change (1Y)
-15
Growth (1Y)
-83.33%
Revenue / Employee
n/a
Profits / Employee
-$14,563,071
Market Cap
298.11K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 3 | -15 | -83.33% | 3 | 0 |
| Dec 31, 2024 | 18 | -3 | -14.29% | 18 | 0 |
| Dec 31, 2023 | 21 | -3 | -12.50% | 21 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Petros Pharmaceuticals News
- 11 months ago - Petros Pharmaceuticals announces deconsolidation of Metuchen subsidiary - TheFly
- 11 months ago - Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position - Accesswire
- 1 year ago - Petros Pharmaceuticals announces transition from Nasdaq to OTC Markets - TheFly
- 1 year ago - Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - Accesswire
- 1 year ago - Petros Pharmaceuticals partners with Innolitics - TheFly
- 1 year ago - Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - Accesswire
- 1 year ago - Petros Pharmaceuticals strengthens partnership with big data provider - TheFly
- 1 year ago - Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - Accesswire